Dr Reddy’s Laboratories has introduced Nerivio in India, a wearable therapy device approved by the United States Food and Drug Administration (USFDA) for drug-free migraine management. Nerivio is the first US FDA-approved device designed for preventing and treating migraines, offering both acute and prophylactic (preventive) treatment for patients aged 12 and above. The device, worn on the upper arm, features 18 built-in 45-minute treatment sessions and stimulates nerve endings to activate conditioned pain modulation, initiating a natural pain-relieving process in the brainstem. Nerivio aims to reduce pill burden and dependency on non-specific medication in migraine treatment.